Mitral Stenosis Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Mitral Stenosis?
Mitral Stenosis occurs when the opening of the mitral valve becomes narrowed, making it harder for blood to move from the left atrium into the left ventricle. Rheumatic heart disease is the most common cause worldwide, although mitral stenosis can also result from valve calcification, congenital abnormalities, or other less common conditions. Severe disease can lead to pulmonary hypertension, atrial fibrillation, heart failure, and other complications.
What is the Importance of Timely Treatment?
Timely treatment can help relieve breathlessness and other symptoms, reduce pressure on the heart and lungs, manage complications such as atrial fibrillation, and prevent worsening heart failure. Regular assessment helps determine whether continued monitoring, symptom or complication medications, percutaneous mitral commissurotomy, or valve surgery is appropriate based on symptoms, disease severity, valve anatomy, and overall health.
What are the Common Symptoms of Mitral Stenosis?
- Shortness of Breath: Breathlessness may occur during physical activity and can become more noticeable as the valve narrowing progresses.
- Fatigue: Reduced blood flow into the left ventricle may contribute to tiredness and reduced physical endurance.
- Palpitations: An irregular or rapid heartbeat may occur, particularly when atrial fibrillation develops.
- Reduced Exercise Tolerance: Routine activities may become increasingly difficult because of breathlessness or fatigue.
- Swelling: Fluid retention may cause swelling of the ankles, feet, or lower legs, particularly in more advanced disease.
- Dizziness or Chest Discomfort: Some patients may experience lightheadedness or chest discomfort, especially during exertion.
Causes and Risk Factors of Mitral Stenosis
Causes
- Rheumatic Heart Disease: Previous rheumatic fever can cause progressive scarring and narrowing of the mitral valve and remains the most common cause worldwide.
- Mitral Valve Calcification: Calcium deposits can progressively restrict valve movement, particularly in older adults.
- Congenital Mitral Stenosis: Some people are born with mitral valve abnormalities that cause narrowing.
- Autoimmune or Inflammatory Conditions: Conditions such as lupus can rarely contribute to mitral valve disease.
- Other Structural Valve Changes: Less common abnormalities may also interfere with normal mitral valve opening.
Risk Factors
- Previous rheumatic fever or rheumatic heart disease
- Increasing age
- History of valvular heart disease
- Congenital heart abnormalities
- Conditions associated with valve calcification
- Certain autoimmune or inflammatory diseases
- Previous heart valve procedure
Latest Research and Technologies in the Treatment of Mitral Stenosis in Malaysia
- Advanced cardiac centres in Malaysia use multimodality imaging and catheter-based techniques to evaluate and treat mitral valve disease. Depending on the hospital and patient needs, these may include transthoracic and transesophageal echocardiography, three-dimensional echocardiography, cardiac CT and MRI, and catheter-based mitral balloon valvuloplasty. Some specialist centres also provide broader structural heart interventions and advanced cardiac imaging to support treatment planning
Treatment options for Mitral Stenosis
Percutaneous Mitral Balloon Commissurotomy (PMBC): Also known as Percutaneous Mitral Valvuloplasty (PMV), this is a catheter-based, first-line mechanical treatment to split open fused leaflets in patients with favourable rheumatic anatomy (measured via a low Wilkins score).
Mitral Valve Replacement (MVR) : The standard open-surgical option using either a mechanical or bioprosthetic valve, reserved for patients with severe calcification, distorted subvalvular apparatus, or concurrent severe mitral regurgitation.
Cost Start From 11680Explore Options
Transcatheter Mitral Valve Replacement (TMVR): This specialised procedure (such as valve-in-mitral-annular-calcification, or ViMAC) is an emerging option for elderly, high-risk patients with degenerative disease who cannot undergo open surgery.
- Clinical assessment:
- Medical History: Assessment of breathlessness, fatigue, exercise tolerance, palpitations, previous rheumatic fever, heart disease, and medications.
- Physical Examination: Evaluation of heart sounds, heart rhythm, blood pressure, oxygen saturation, signs of fluid retention, and other cardiovascular findings.
- Electrocardiogram (ECG): May identify atrial fibrillation, heart-rate abnormalities, or other cardiac changes.
- Blood Tests: Blood tests may assess kidney function, electrolytes, blood counts, and other treatment-relevant factors.
- Exercise Testing: Exercise or stress testing may be considered when symptoms and resting valve measurements do not clearly correspond.
- Imaging Tests:
- Transthoracic Echocardiography (TTE): The standard initial imaging test used to assess valve structure, valve area, blood-flow gradients, heart chambers, and pulmonary pressures.
- Transesophageal Echocardiography (TEE): Provides detailed images of the mitral valve and left atrium and may be used before percutaneous commissurotomy to assess for blood clots and valve anatomy.
- Three-Dimensional Echocardiography: Provides detailed assessment of valve morphology and can support procedural planning in selected patients.
- Cardiac CT: May provide additional anatomical information, particularly when valve or mitral annular calcification needs further assessment.
- Cardiac MRI: Provides detailed information about heart structure and function in selected patients.
- Chest X-ray: May show enlarged cardiac chambers or changes associated with pulmonary congestion.
- Cardiac Catheterisation: Can measure pressures within the heart and pulmonary circulation when non-invasive testing does not provide sufficient information or before selected interventions.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support mitral stenosis patients in Malaysia. These services include:
- Cardiac Rehabilitation: Structured rehabilitation may help improve exercise capacity and support recovery after valve procedures.
- Gradual Physical Activity: Increase activity according to symptoms, valve severity, heart function, and medical advice.
- Breathing and Functional Training: Selected patients may benefit from supervised exercises to improve functional capacity.
- Long-Term Cardiac Follow-Up: Regular cardiology and valve-clinic assessments help monitor valve function, heart rhythm, symptoms, and treatment response.
- Medicines for mitral stenosis may include diuretics, heart-rate-controlling medicines, medicines for atrial fibrillation, and anticoagulants when indicated. These treatments can reduce symptoms and manage complications but do not reverse severe mechanical narrowing of the mitral valve. In rheumatic mitral stenosis with atrial fibrillation, anticoagulation decisions require particular consideration because thromboembolic risk is increased.
Instantly Connect with our Specialists
Hospitals for Mitral Stenosis in Malaysia
ParkCity Medical Centre
Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.
Bukit Tinggi Medical Centre
Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Damansara Specialist Hospital 2 (DSH2), Kuala Lumpur
Kuala Lumpur, Malaysia
- The KPJ Damansara Specialist Hospital 2 in Malaysia is a multidisciplinary centre providing care across a range of specialities, including cardiology, oncology, orthopaedics, neurology, gastroenterology, women’s health, paediatrics, and minimally invasive surgery. The hospital uses evidence-based treatment methods and has advanced diagnostic and rehabilitation capabilities, and provides patient-centred care through experienced specialists and the latest technology. The hospital has an experienced team that provides comprehensive additional services to patients from other countries, including pre-therapy planning, recovery, and rehabilitation assistance, making it a leader in private healthcare in Malaysia.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Mitral Stenosis Treatment?
- Experienced Cardiac Specialists: Access to cardiologists, interventional cardiologists, and cardiac surgeons experienced in managing valvular heart disease.
- Advanced Valve Diagnostics: Major cardiac centres may offer advanced echocardiography, 3D imaging, cardiac CT, cardiac MRI, and catheter-based assessment.
- Percutaneous Valve Procedures: Eligible patients may have access to percutaneous mitral balloon commissurotomy and other catheter-based interventions.
- Cardiac Surgery: Specialised centres can provide mitral valve repair, commissurotomy, and valve replacement when required.
- Multidisciplinary Heart Teams: Cardiologists, cardiac surgeons, imaging specialists, anaesthesiologists, and rehabilitation teams can collaborate on complex cases.
- Personalised Treatment Planning: Treatment selection can consider valve anatomy, symptoms, pulmonary pressures, heart rhythm, age, associated conditions, and procedural risk.
- Comprehensive Follow-Up: Long-term monitoring can help manage valve function, rhythm abnormalities, anticoagulation, and other complications.
- International Patient Support: Many major Malaysia hospitals assist international patients with appointments, treatment coordination, accommodation, and follow-up.
Frequently Asked Questions
Author
Alvina Hasan
Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.
With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.
Readers can explore her published research and articles here:
https://carcinogenesis.com/index.php/JOC/article/view/868
https://carcinogenesis.com/index.php/JOC/article/view/870
View MoreReviewer
Dr. Nityanand Tripathi
Interventional Cardiologist
29 Years of Experience
With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More
Last Reviewed - January 2026